Advances in cell-type specific delivery of RNAi-based therapeutics

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


RNAi-based gene silencing mechanisms have emerged as indispensible tools for experimentally induced, sequence-specific inhibition of gene expression. The translation of these technologies for therapeutic applications has required the development of clinically feasible delivery strategies that facilitate the uptake of the siRNAs by specific cell type(s) and tissues. This feature review focuses on the progress made in the targeted delivery of siRNAs and the challenges encountered in the development of safe and effective therapeutic silencing agents.

Original languageEnglish (US)
Pages (from-to)325-331
Number of pages7
Issue number5
StatePublished - May 1 2010


  • Cell type-specific delivery
  • RNAi
  • SiRNA
  • Therapeutic gene silencing

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Advances in cell-type specific delivery of RNAi-based therapeutics'. Together they form a unique fingerprint.

Cite this